Glenview Trust Co Invests $5.77 Million in Cigna Group $CI

Glenview Trust Co purchased a new stake in shares of Cigna Group (NYSE:CI) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 20,914 shares of the health services provider’s stock, valued at approximately $5,766,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Wilkerson Advisory Group LLC bought a new position in Cigna Group during the fourth quarter valued at about $25,000. Osbon Capital Management LLC acquired a new stake in shares of Cigna Group in the second quarter worth about $26,000. Johnson Financial Group Inc. bought a new stake in shares of Cigna Group during the 2nd quarter worth about $29,000. Kemnay Advisory Services Inc. acquired a new position in shares of Cigna Group during the 4th quarter valued at about $29,000. Finally, Prosperity Bancshares Inc acquired a new position in shares of Cigna Group during the 4th quarter valued at about $29,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Trading Down 1.3%

Cigna Group stock opened at $277.21 on Friday. The business has a 50 day moving average price of $283.53 and a two-hundred day moving average price of $281.41. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The stock has a market cap of $73.25 billion, a price-to-earnings ratio of 11.47, a price-to-earnings-growth ratio of 0.97 and a beta of 0.29.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The company had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period last year, the firm earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts forecast that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s dividend payout ratio is 25.82%.

Insiders Place Their Bets

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Nicole S. Jones sold 2,677 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the transaction, the insider owned 25,880 shares in the company, valued at $7,236,306.80. The trade was a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 23,012 shares of company stock valued at $6,386,550 over the last ninety days. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Guggenheim raised their price objective on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Piper Sandler lowered their price target on Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a report on Wednesday, June 3rd. Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and lowered their price target for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Cantor Fitzgerald lifted their price target on shares of Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. Finally, Mizuho boosted their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Fifteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $339.45.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.